LumiraDx reports revenue increases for Q1

2021 01 11 17 03 4617 Covid Diagnostic Test Kit 400

Point-of-care diagnostics company LumiraDx reported revenue increases for the first quarter of the 2022 fiscal year, with revenues driven in part by sales of COVID-19-related products.

The company said revenues for the quarter were $126.4 million, compared to $106.9 million for the first quarter of 2021. The company's net loss for the quarter, meanwhile, was $55.7 million.

The company said these numbers were driven by growing its installed customer base to 25,000 platforms, as well as sales of COVID-19 related-products at the height of the omicron variant wave.

Page 1 of 9
Next Page